Teladoc Health is promising fewer disconnected tools for hospital virtual care, but its two new AI capabilities arrive at different stages. In its October 7, 2026 announcement, the company made SoloScribe documentation generally available. SoloVitals, which measures heart and breathing rates through a patient’s camera, is in private preview, with a full release expected in December 2026.
The camera becomes an intake tool
SoloVitals uses a camera-equipped device, such as a smartphone or tablet, to capture measurements without touching the patient. The technique is called remote photoplethysmography, or rPPG: software analyzes tiny changes in facial skin color associated with blood flow to generate vital-sign readings.
Danny Sanchez, Teladoc’s vice president of technology and innovation, told MedCity News that the system also assesses patients’ fine movements using computer vision. Algorithms combine those signals to return the supported measurements: heart rate and respiration rate, or the rate of breathing.
The capture happens during virtual-visit intake. Sanchez said on-screen prompts guide patients through the process, with no separate app download required. Results become available to the provider before or during the consultation, placing the measurements in the visit rather than in a separate patient-facing tool.
Teladoc describes the measurements as clinically validated. Its announcement does not provide accuracy figures or details of the validation study, leaving the basis for that clinical claim unexplained in the launch materials.
“Our clients keep telling us they want the opposite: new capabilities built into the products and workflows they already know and use.”
Danny Sanchez, Teladoc Health vice president of technology and innovation, speaking to MedCity News
Notes move into the health record
SoloScribe handles a different part of the encounter. The ambient AI scribe creates structured clinical notes within Solo, then transfers a templated summary into the electronic health record, or EHR. Teladoc’s stated aim is to let clinicians concentrate on the patient while documentation remains inside the virtual-care workflow.
The documentation capability supports both direct-to-patient visits and encounters conducted through telemedicine devices. Teladoc says that gives hospitals one integrated Solo experience for extending AI-assisted documentation across eligible clinicians, programs and workflows, rather than requiring a separate documentation product for each setting.
An existing platform is the distribution route
Both capabilities are embedded in Solo, Teladoc’s enterprise care platform for hospitals and health systems. The company frames that design as a response to technology fragmentation: adding functions inside an existing platform instead of asking care teams to navigate more disconnected tools and vendors.
Teladoc says Solo is installed in more than 15,000 care locations globally—a location count, not a customer count. The platform already integrates with Epic and Oracle Health electronic health records using HL7 and FHIR, standards for exchanging healthcare information. Those connections provide the existing record-system infrastructure for the new documentation workflow.
Reader comments
Newest comments first. Replies stay oldest first.